Real-Time EHR-to-EDC Technology Slashes Clinical Trial Data-Entry Time at Mount Sinai
The Mount Sinai Tisch Cancer Center has deployed real-time EHR-to-EDC technology across all 16 of its cancer disease groups, cutting ...
The Mount Sinai Tisch Cancer Center has deployed real-time EHR-to-EDC technology across all 16 of its cancer disease groups, cutting ...
A $4 million NIH-funded five-year study led by UCLA Health and Mount Sinai will investigate why IBS-like symptoms persist in ...
A Mount Sinai retrospective analysis suggests GLP-1 receptor agonists may reduce cardiovascular risk, inflammation, and disease severity in hidradenitis suppurativa.
Mount Sinai has received a $2 million NIH grant to launch the U.S. feasibility phase of SCAD-ALIGN, an international trial ...
A Mount Sinai study published in Science shows that loss of the tumor suppressor p53 reorganizes Wnt signaling into a ...
Mount Sinai will honor vascular biologist Napoleone Ferrara, whose 1989 discovery of VEGF produced groundbreaking therapies for cancer and blinding ...
In a landmark development for the intersection of artificial intelligence and healthcare, Dr. Girish N. Nadkarni has been appointed the ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine